| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.068 | 0.1 |